Combination of direct and indirect evidence in mixed treatment comparisons

Stat Med. 2004 Oct 30;23(20):3105-24. doi: 10.1002/sim.1875.


Mixed treatment comparison (MTC) meta-analysis is a generalization of standard pairwise meta-analysis for A vs B trials, to data structures that include, for example, A vs B, B vs C, and A vs C trials. There are two roles for MTC: one is to strengthen inference concerning the relative efficacy of two treatments, by including both 'direct' and 'indirect' comparisons. The other is to facilitate simultaneous inference regarding all treatments, in order for example to select the best treatment. In this paper, we present a range of Bayesian hierarchical models using the Markov chain Monte Carlo software WinBUGS. These are multivariate random effects models that allow for variation in true treatment effects across trials. We consider models where the between-trials variance is homogeneous across treatment comparisons as well as heterogeneous variance models. We also compare models with fixed (unconstrained) baseline study effects with models with random baselines drawn from a common distribution. These models are applied to an illustrative data set and posterior parameter distributions are compared. We discuss model critique and model selection, illustrating the role of Bayesian deviance analysis, and node-based model criticism. The assumptions underlying the MTC models and their parameterization are also discussed.

Publication types

  • Comparative Study

MeSH terms

  • Adrenergic beta-Antagonists / standards
  • Adrenergic beta-Antagonists / therapeutic use
  • Bayes Theorem*
  • Data Interpretation, Statistical*
  • Fibrosis / pathology
  • Fibrosis / therapy
  • Hemorrhage / pathology
  • Hemorrhage / therapy
  • Humans
  • Markov Chains
  • Meta-Analysis as Topic*
  • Models, Statistical*
  • Monte Carlo Method
  • Randomized Controlled Trials as Topic / methods*
  • Sclerotherapy / standards


  • Adrenergic beta-Antagonists